State of New Jersey Common Pension Fund D
MLYS icon

State of New Jersey Common Pension Fund D’s Mineralys Therapeutics MLYS Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$486K Buy
17,996
+2,392
+15% +$65.6K ﹤0.01% 1631
2026
Q1 		$423K Buy
15,604
+20
+0.1% +$587 ﹤0.01% 1472
2025
Q4 		$566K Buy
+15,584
New +$625K ﹤0.01% 1439

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

State of New Jersey Common Pension Fund D's MLYS Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D increased its Mineralys Therapeutics (MLYS) stake by 15% in Q2 2026, buying an estimated $65.6K and bringing the position to 17,996 shares worth $486K. The position accounts for ﹤0.01% of the portfolio, ranked #1631.

State of New Jersey Common Pension Fund D first reported a position in MLYS in Q4 2025 and has held it in 3 quarters since. The position peaked at $566K in Q4 2025. 77 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 17,996 shares of Mineralys Therapeutics worth $486K as of Q2 2026.
  • State of New Jersey Common Pension Fund D bought 2,392 Mineralys Therapeutics shares in Q2 2026, an estimated $65.6K.
  • Mineralys Therapeutics made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1631 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Mineralys Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • State of New Jersey Common Pension Fund D's Mineralys Therapeutics position peaked at $566K in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.